Association of haplotypes of interleukin-10 gene with the risk of cancer

Bulletin of Experimental Biology and Medicine

Volumn 144, Issue 3, 2007, Pages 385-389

  Pogoda, T V ^a   Marsheva, O V ^a   Kostin, P A ^a   Maksimov, V N ^b   Kulikov, I V ^b   Openko, T G ^b   Simonova, G I ^b   Voyevoda, M I ^b   Generozov, E V ^a   Govorun, V M ^a  

^a Federal Agency for Health Care and Social Development   (Russian Federation)

^b INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Cancer; Genetic predisposition; Haplotypes; Interleukin 10

Indexed keywords

GENOMIC DNA; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 8;

ARTICLE; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CAUCASIAN; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NEOPLASM; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-8; NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 37749036699     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0339-9     Document Type: Article

References (15)

1. Z. G. Kadagidze, Prakt. Onkol., 3, 131-139 (2003).
2. R. Alonso, A. Suarez, P. Castro, et al., Melanoma Res., 15, No. 1, 53-60 (2005).
3. M. A. Gordon, J. Gil, B. Lu, et al., Pharmacogenomics, 7, No. 1, 67-88 (2006).
4. E. Havranek, W. M. Howell, H. M. Fussell, et al., J. Urol., 173, No. 3, 709-712 (2005).
5. K. Koss, G. C. Fanning, K. I. Welsh, and D. P. Jewell, Genes Immun., 1, No. 5, 321-324 (2000).
6. U. Langsenlehner, P. Krippl, W. Renner, et al., Breast Cancer Res. Treat., 90, No. 2, 113-115 (2005).
7. H. T. Lynch and P. M. Lynch, Dis. Colon Rectum, 22, No. 2, 106-110 (1979).
8. M. Macarthur, L. Sharp, G. L. Hold, et al., Cancer Epidemiol. Biomarkers Prev., 14, No. 7, 1613-1618 (2005).
9. B. A. Ponder, Nature, 411, No. 6835, 336-341 (2001).
10. J. E. Portielje, J. W. Gratama, H. H. van Ojik, et al., Cancer Immunol. Immunother., 52, No. 3, 133-144 (2003).
11. T. R. Rebbeck, F. J. Couch, J. Kant, et al., Am. J. Hum. Genet., 59, No. 3, 547-553 (1996).
12. H. D. Shin, B. L. Park, L. H. Kim, et al., Hum. Mol. Genet., 12, No. 8, 901-906 (2003).
13. B. L. Weber and K. L. Nathanson, Eur. J. Cancer, 36, No. 10, 1193-1199 (2000).
14. M. Wjst, J. Altmuller, T. Faus-Kessler, et al., Respir. Res., 7, 60 (2006).
15. K. Xie, Cytokine Growth Factor Res., 12, No. 4, 375-391 (2001).